Format

Send to

Choose Destination
Clin Chest Med. 2009 Sep;30(3):479-88, viii. doi: 10.1016/j.ccm.2009.05.002.

Obesity and asthma.

Author information

1
National Jewish Health and Department of Pulmonary and Critical Care Medicine, University of Colorado at Denver Health Sciences Programs, Denver, CO 80206, USA. beutherd@njhealth.org

Abstract

Population-based studies have defined a significant, bidirectional, dose-dependent association between obesity and asthma. Obesity does not cause airflow obstruction, but can result in pulmonary restriction and a reduction in airway diameter, and that could contribute to airway hyper-responsiveness. Mouse models of asthma have demonstrated that obesity and adipokines can enhance airway hyper-responsiveness, airway inflammation, and allergic responses, but it is unclear whether obesity-associated inflammatory mechanisms are relevant in human asthma. Shared environmental and genetic factors are incompletely understood, but very likely to be relevant. Obese asthma appears to be a distinct and novel phenotype of asthma, associated with a reduction in lung volumes, lack of eosinophilic inflammation, altered response to asthma controller therapy, glucocorticoid resistance, and poor asthma control.

PMID:
19700046
DOI:
10.1016/j.ccm.2009.05.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center